Dermatology · Mount Pleasant, WI
NPI
1285976209
Since 2013
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1300 S Green Bay Rd Ste 100
Mount Pleasant, WI, 53406
Phone (262) 619-4191
Groups this clinician bills Medicare through
Medicare paid, 2024
$92K
1,993 services
Medicare patients, 2024
452
Average age 74
Drug cost, 2024
$989K
1,029 prescriptions
Company payments, 2025
$831
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael B Dreifke was code 17003 (destruction skin lesion), 475 times for 98 patients. In total Michael B Dreifke billed 1,993 services in 46 codes, and Medicare paid $92K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 475 | 98 | $4.74 | $2,251 |
| 99213 Office E&M - Established | Office | 445 | 298 | $59.09 | $26K |
| 17000 Destruction Skin Lesion | Office | 203 | 147 | $36.52 | $7,413 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 129 | 26 | $0.77 | $99.74 |
| 17110 Destruction Skin Lesion | Office | 128 | 98 | $73.42 | $9,397 |
| 99214 Office E&M - Established | Office | 103 | 76 | $85.24 | $8,779 |
| 99212 Office E&M - Established | Office | 83 | 75 | $37.03 | $3,074 |
| 99203 Office E&M - New | Office | 59 | 59 | $66.38 | $3,917 |
| 11301 Removal or Shaving of Skin Growth | Office | 49 | 48 | $78.95 | $3,869 |
| 11300 Removal or Shaving of Skin Growth | Office | 37 | 36 | $62.54 | $2,314 |
| 12032 Wound Repair - All Levels | Office | 27 | 24 | $232.80 | $6,285 |
| 11310 Removal or Shaving of Skin Growth | Office | 26 | 25 | $78.71 | $2,046 |
| 96372 Injection Administration | Office | 25 | 19 | $10.93 | $273 |
| 11602 Skin Lesion Excision | Office | 21 | 17 | $101.37 | $2,129 |
| 36415 Venipuncture Blood Collection | Office | 19 | 11 | $8.65 | $164 |
By year: 2022 $86K for 1,679 services; 2023 $102K for 2,169 services; 2024 $92K for 1,993 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 19 | 11 | $8.65 | $164 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael B Dreifke prescribed most often to Medicare patients was Triamcinolone Acetonide, with 167 prescriptions and refills. In total Michael B Dreifke wrote 1,029 Medicare prescriptions that cost $989K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 167 | 174 | 121 | $1,550 |
| Ketoconazole Generic | 115 | 119 | 72 | $1,907 |
| Clobetasol Propionate Generic | 90 | 98 | 62 | $2,805 |
| Dupixent Pen Dupilumab | 40 | 40 | Under 11 | $160K |
| Doxycycline Monohydrate Generic | 37 | 55 | 21 | $902 |
| Hydrocortisone Generic | 31 | 31 | 25 | $157 |
| Methotrexate Methotrexate Sodium | 29 | 56 | Under 11 | $120 |
| Mometasone Furoate Generic | 28 | 28 | 22 | $552 |
| Fluocinonide Generic | 24 | 26 | 17 | $852 |
| Mupirocin Generic | 24 | 24 | 21 | $208 |
| Cosentyx Sensoready (2 Pens) Secukinumab | 23 | 23 | Under 11 | $178K |
| Mycophenolate Mofetil Generic | 21 | 23 | Under 11 | $1,063 |
| Metronidazole Generic | 19 | 19 | 15 | $843 |
| Otezla Apremilast | 19 | 21 | Under 11 | $100K |
| Fluorouracil Generic | 18 | 19 | 15 | $1,062 |
Brand drugs: 164 claims; generic drugs: 865 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael B Dreifke $831 ($831 in general payments such as food, travel and fees) from 14 companies. The largest payer was UCB, Inc. with $125.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 5 | $125 |
| Regeneron Healthcare Solutions, Inc. REGN | 4 | $93.48 |
| Abbvie Inc. ABBV | 6 | $92.8 |
| Janssen Biotech, Inc. JNJ | 4 | $91.15 |
| Lilly USA, LLC LLY | 4 | $74.02 |
| Incyte Corporation INCY | 3 | $65.86 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $65.27 |
| LEO Pharma Inc. | 2 | $55.37 |
| Genzyme Corporation SNY | 2 | $52.49 |
| Amgen Inc. AMGN | 2 | $51.32 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.